Tarsus Pharmaceuticals, Inc. (TARS)
TARS has a market cap or net worth of $516.92 million. The enterprise value is $333.12 million.
The latest earnings date was Wednesday, November 10, 2021 before market open.
|Last Earnings Date||Nov 10, 2021|
TARS has 20.68 million shares outstanding. The number of shares has increased by 656.18% in one year.
|Shares Change (YoY)||+656.18%|
|Shares Change (QoQ)||+0.42%|
|Owned by Insiders (%)||28.57%|
|Owned by Institutions (%)||62.60%|
The stock's EV/EBITDA ratio is n/a, with a EV/FCF ratio of 59.55.
|EV / Earnings||n/a|
|EV / Sales||5.88|
|EV / EBITDA||n/a|
|EV / EBIT||n/a|
|EV / FCF||59.55|
|Debt / Equity||n/a|
|Debt / EBITDA||n/a|
|Debt / FCF||n/a|
|Return on Equity (ROE)||-5.80%|
|Return on Assets (ROA)||-5.50%|
|Return on Capital (ROIC)||-108.30%|
|Revenue Per Employee||$2.83M|
|Profits Per Employee||-$522,150|
In the past 12 months, TARS has paid $1,000 in taxes.
|Effective Tax Rate||-0.01%|
Stock Price Statistics
The stock price has increased by +8.70% in the last 52 weeks.
|52-Week Price Change||+8.70%|
|50-Day Moving Average||27.31|
|200-Day Moving Average||27.17|
|Average Volume (30 Days)||31,674|
Short Selling Information
|Short % of Shares Out||1.56%|
|Short % of Float||5.80%|
|Short Ratio (days to cover)||9.83|
In the last 12 months, TARS had revenue of $56.69 million and -$10.44 million in losses. Earnings per share was -$0.53.
|Earnings Per Share (EPS)||-$0.53|
|Cash & Cash Equivalents||183.80M|
|Net Cash Per Share||$8.89|
|Book Value Per Share||8.66|
In the last 12 months, operating cash flow was $5.86 million and capital expenditures -$262,000, giving a free cash flow of $5.59 million.
|Operating Cash Flow||5.86M|
|Free Cash Flow||5.59M|
|FCF Per Share||$0.27|
Gross margin is 96.30%, with operating and profit margins of -16.20% and -18.42%.
Dividends & Yields
TARS does not appear to pay any dividends at this time.
|Dividend Per Share||n/a|
|Dividend Growth (YoY)||n/a|
This stock does not have any record of stock splits.
|Last Split Date||n/a|